학술논문
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma
Document Type
Article
Author
Source
In Blood 4 February 2021 137(5):637-645
Subject
Language
ISSN
0006-4971